| Symbol |
Name |
|
ACO1
|
aconitase 1, soluble
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARFIP2
|
ADP-ribosylation factor interacting protein 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ASF1A
|
anti-silencing function 1A histone chaperone
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ATF2
|
activating transcription factor 2
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BLNK
|
B-cell linker
|
|
BORA
|
bora, aurora kinase A activator
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta)
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDH13
|
cadherin 13
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRY2
|
cryptochrome circadian clock 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTTN
|
cortactin
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP16
|
dual specificity phosphatase 16
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FBXO31
|
F-box protein 31
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FHIT
|
fragile histidine triad
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FUS
|
FUS RNA binding protein
|
|
GJA8
|
gap junction protein, alpha 8, 50kDa
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
H2AFX
|
H2A histone family, member X
|
|
HDAC4
|
histone deacetylase 4
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTT
|
huntingtin
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL33R
|
interleukin 33 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ING1
|
inhibitor of growth family, member 1
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS1
|
insulin receptor substrate 1
|
|
JAK2
|
Janus kinase 2
|
|
JDP2
|
Jun dimerization protein 2
|
|
JUN
|
jun proto-oncogene
|
|
KDR
|
kinase insert domain receptor
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KRT8
|
keratin 8, type II
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1
|
|
MARK2
|
MAP/microtubule affinity-regulating kinase 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MFN2
|
mitofusin 2
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MVB12B
|
multivesicular body subunit 12B
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYOD1
|
myogenic differentiation 1
|
|
NACA
|
nascent polypeptide-associated complex alpha subunit
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCSTN
|
nicastrin
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEUROG1
|
neurogenin 1
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L1
|
nuclear factor, erythroid 2-like 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
OAZ2
|
ornithine decarboxylase antizyme 2
|
|
OCLN
|
occludin
|
|
ORC1
|
origin recognition complex, subunit 1
|
|
ORC2
|
origin recognition complex, subunit 2
|
|
PDCL
|
phosducin-like
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PGR
|
progesterone receptor
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1
|
|
PKN1
|
protein kinase N1
|
|
PLK4
|
polo-like kinase 4
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C
|
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PSMA2
|
proteasome (prosome, macropain) subunit, alpha type, 2
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7
|
|
PSMB4
|
proteasome (prosome, macropain) subunit, beta type, 4
|
|
PSMB6
|
proteasome (prosome, macropain) subunit, beta type, 6
|
|
PSMC5
|
proteasome (prosome, macropain) 26S subunit, ATPase, 5
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PXN
|
paxillin
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG2
|
recombination activating gene 2
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM17
|
RNA binding motif protein 17
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RHOA
|
ras homolog family member A
|
|
RHOT1
|
ras homolog family member T1
|
|
RNF7
|
ring finger protein 7
|
|
RPL13A
|
ribosomal protein L13a
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIK1
|
salt-inducible kinase 1
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIRT1
|
sirtuin 1
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SP1
|
Sp1 transcription factor
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STMN1
|
stathmin 1
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
SYK
|
spleen tyrosine kinase
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBL1X
|
transducin (beta)-like 1X-linked
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX21
|
T-box 21
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLN1
|
talin 1
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TTC3
|
tetratricopeptide repeat domain 3
|
|
TTK
|
TTK protein kinase
|
|
UBXN1
|
UBX domain protein 1
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
VCP
|
valosin containing protein
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
ZC3HC1
|
zinc finger, C3HC-type containing 1
|
|
ZFP36
|
ZFP36 ring finger protein
|